Your browser doesn't support javascript.
loading
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials.
Dejgaard, Thomas F; von Scholten, Bernt J; Christiansen, Erik; Kreiner, Frederik F; Bardtrum, Lars; von Herrath, Matthias; Mathieu, Chantal; Madsbad, Sten.
Affiliation
  • Dejgaard TF; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • von Scholten BJ; Novo Nordisk A/S, Søborg, Denmark.
  • Christiansen E; Novo Nordisk A/S, Søborg, Denmark.
  • Kreiner FF; Novo Nordisk A/S, Søborg, Denmark.
  • Bardtrum L; Novo Nordisk A/S, Søborg, Denmark.
  • von Herrath M; Novo Nordisk A/S, Søborg, Denmark.
  • Mathieu C; University of Leuven, Leuven, Belgium.
  • Madsbad S; Hvidovre University Hospital, University of Copenhagen, Hvidovre, Denmark.
Diabetes Obes Metab ; 23(12): 2752-2762, 2021 12.
Article in En | MEDLINE | ID: mdl-34463425
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Liraglutide Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Type: Article Affiliation country: Denmark
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Liraglutide Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Type: Article Affiliation country: Denmark